alfuzosin

Alfuzosin hydrochloride (Alfuzosin HCl) is an α1 adrenergic receptor antagonist. It applies to treat benign prostatic hyperplasia (BPH).

Deacylated alfuzosin is a biochemical.

Alfuzosin (SL 77499) is an orally available, competitive α1-adrenoceptor antagonist.Alfuzosin induces smooth muscle relaxation in the bladder neck and prostate.Alfuzosin has been used to study benign prostatic hypertrophy, lower urinary tract symptoms (LUTS), and ejaculatory dysfunction (EjD).

Terazosin-md (compound TZ-md) is a derivative of Alfuzosin and Terazosin, functioning as an orally active α1-adrenergic receptor antagonist. It enhances mitochondrial metabolism, degrades various pathological protein deposits, and improves vascular endothelial cell function. Moreover, Terazosin-md has shown activity in mouse models of Alzheimer's disease. This compound can be utilized in the research of Alzheimer's disease, its complications, and disorders associated with protein aggregation and metabolic imbalances.